SINOVAC BIOTECH LTD

SVA ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $114.4M $62.4M $63.8M $89.8M $106.5M $91.2M $104.3M $101.6M
Accounts Receivable $66.2M $49.8M $39.0M $40.7M $31.9M $23.4M $17.8M $22.4M
Inventory $19.6M $14.1M $18.7M $18.7M $14.3M $10.5M $8.1M $14.5M
Total Current Assets $203.9M $130.7M $128.5M $154.8M $157.3M $126.3M $132.0M $147.0M
Property, Plant & Equipment $76.4M $66.9M $63.9M $66.2M $68.0M $69.2M $75.6M $64.0M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — $1.1M $1.3M —
Total Assets $299.2M $211.4M $202.9M $238.5M $240.7M $208.8M $215.9M $214.4M
Liabilities
Accounts Payable $6.8M $1.8M $1.7M $3.0M $6.1M $2.2M $2.9M $22.1M
Total Current Liabilities $92.5M $66.3M $58.1M $79.8M $49.2M $30.2M $39.5M $45.8M
Long-Term Debt $33.0M $40.7M — — — — — —
Total Liabilities $122.1M $81.7M $66.4M $96.8M $97.1M $79.3M $70.6M $66.6M
Stockholders' Equity
Retained Earnings $9.1M $-11.9M $-10.0M $-6.4M — — $2.7M $3.9M
Total Stockholders' Equity $151.2M $115.8M $121.7M $126.6M $128.7M $117.7M $129.9M $126.4M
← Newer Page 2 of 2 Older →